Lupin, Inc.

Satish Kumar Dalal

Harshal Jahagirdar

Shirishkumar Kulkarni

Ashish Ashokrao Deshmukh

Pravin Meghrajji Bhutada

Kishore Kumar Konda

Shirish Kumar Kulkarni

Srirupa Das

Sheetal Kulkarni

Harshal Anil Jahagirdar

The present invention provides a modified release formulation of lacosamide. The modified release formulation of the present invention comprising lacosamide and modified release polymer provides modified release of lacosamide with minimal Cto Cpeak to trough variation over a period of at least 12 hrs.

Modified release formulation of lacosamide

A stable, taste-masked, ready-to-use suspension comprising rifaximin dispersed in a suspension base and one or more pharmaceutically acceptable additive(s). Also provided is a process for preparing a stable, taste-masked, ready-to-use suspension of rifaximin comprising the steps of mixing rifaximin with the suspension base and further sizing the particles of rifaximin by milling the suspension to obtain a homogenously dispersed rifaximin suspension.

Rifaximin ready-to-use suspension

The present invention relates to a method of reducing the incidence of nausea and vomiting associated with the administration of oral contraceptive formulation and a method of preparation of oral contraceptive formulation comprising progestin and/or estrogen and an antiemetic. The preferred oral contraceptive formulation comprises of levonorgestrel and an antiemetic.

Antiemetic-oral contraceptive combination

Growing community of inventors

Pune, India

Satish Kumar Dalal